RDZN Stock Analysis & Morning Insights for Investors

7/28/2025

Comprehensive Analysis

Financial Health

Roadzen Inc. (RDZN) exhibits severe financial distress, with negative equity of -$29.92 billion as of Q4 2024 and a current ratio of 0.42, indicating acute liquidity constraints. Despite TTM revenue of $42.89 billion (up from $13.56 billion in 2023), the company remains unprofitable, with TTM net income of -$106.7 billion and EBIT of -$93.31 billion. Free cash flow is persistently negative (-$15.37 billion TTM), necessitating continuous external financing to sustain operations. The Altman Z-Score is inapplicable due to negative equity, but the debt-to-equity ratio is effectively infinite, signaling extreme solvency risk.